Yong Seog Oh

Quick facts

Phase 3 pipeline

• Adenosine arm
  Adenosine arm likely refers to a therapeutic strategy leveraging adenosine signaling pathways, potentially for immunomodulation or cardioprotection.
• Continuous heparin infusion · Cardiovascular
  Heparin is an anticoagulant that inhibits multiple clotting factors to prevent thrombus formation.
• Intermittent heparin infusion · Cardiovascular
  Intermittent heparin infusion prevents blood clot formation by inhibiting thrombin and other coagulation factors through periodic intravenous administration.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Yong Seog Oh portfolio CI brief
• Yong Seog Oh pipeline updates RSS